Literature DB >> 10559619

Possible causes of unsuccessful endoscopic collagen treatment of vesicoureteric reflux in children.

B Trsinar1, D Cotic, C Oblak.   

Abstract

OBJECTIVE: The purpose of this prospective study was to identify possible causes of unsuccessful treatment of vesicoureteric reflux (VUR) in children by endoscopic collagen injection. PATIENTS AND METHODS: Between February 1994 and September 1996, 130 primary VURs in 94 children aged 3-16 years were treated by endoscopic injection of collagen. Grade 2 VUR was found in 46 ureteric units, grade 3 in 55, and grade 4 in 11 ureteric units. Seventy-seven children had normal micturition, and 17 showed signs of an unstable bladder. The collagen injection was performed under general anaesthesia. All children had a follow-up assessment on average 5.1 months after the first injection of collagen. They were evaluated by micturition cystography and ultrasound examination of the urinary tract.
RESULTS: A single injection of collagen eliminated VUR in 74 (56.9%) cases. There was a statistically significant correlation between the grade of VUR and the success rate of collagen therapy (p < 0.01). The average amount of collagen used in cured and in noncured children was 0.55 and 0.76 ml, respectively (p < 0.01). Children with normal appearance of the ureteric orifice had significantly better results as compared with other children (p < 0.01). There was no statistically significant correlation between the success rate of treatment and the place of collagen injection or the shape of ureteric orifice following the injection. A statistically significant association, however, was found between the function of the lower urinary tract and the results of endoscopic collagen treatment for VUR (p < 0.05). Ultrasound showed no obstruction of the upper urinary tract.
CONCLUSION: High-grade VUR, incorrect technique of injection, and voiding dysfunction seem to be some of the possible causes of an unsuccessful endoscopic collagen treatment of VUR in children. Copyright 1999 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559619     DOI: 10.1159/000020059

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux.

Authors:  Bilal Eryildirim; Fatih Tarhan; Uğur Kuyumcuoğlu; Erkan Erbay; Gökhan Faydaci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Combination of calcium hydroxyapatite and autologous blood for endoscopic treatment of vesicoureteral reflux in children.

Authors:  Roozbeh Tanhaeivash; Abdol-Mohammad Kajbafzadeh; Atefeh Zeinoddini; Neda Khalili; Mona Vahidi Rad; Reza Heidari
Journal:  Int Urol Nephrol       Date:  2014-02-20       Impact factor: 2.370

3.  Prevalence of Bladder and Bowel Dysfunction in Toilet-Trained Children With Urinary Tract Infection and/or Primary Vesicoureteral Reflux: A Systematic Review and Meta-Analysis.

Authors:  Jitendra Meena; Georgie Mathew; Pankaj Hari; Aditi Sinha; Arvind Bagga
Journal:  Front Pediatr       Date:  2020-03-31       Impact factor: 3.418

4.  The influence of ureteral orifice configuration on the success rate of endoscopic treatment of vesicoureteral reflux.

Authors:  Farshid Alizadeh; Amir Abbas Shahdoost; Mahtab Zargham; Farhad Tadayon; Rasoul Hashemi Joozdani; Hamidreza Arezegar
Journal:  Adv Biomed Res       Date:  2013-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.